CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma

Deepu Madduri(Johnson & Johnson (United States)), Thomas Martin(University of California, San Francisco), Saad Z. Usmani(Memorial Sloan Kettering Cancer Center), Yunsi Olyslager(Janssen (Belgium)), Enrique Zudaire(Centro de Investigación del Cáncer), Mounzer Agha(Dana-Farber Cancer Institute), Myo Htut(City Of Hope National Medical Center), Adam D. Cohen(Penn Center for AIDS Research), Sundar Jagannath(Mount Sinai Hospital), Parameswaran Hari(Medical College of Wisconsin), Alexander M. Lesokhin(Memorial Sloan Kettering Cancer Center), Syed Rizvi(Merck (Japan)), Nikhil C. Munshi(Dana-Farber Cancer Institute), Jesús G. Berdeja(Tennessee Oncology), Abhinav Deol(Wayne State University), David Avigan(Beth Israel Deaconess Medical Center), Elizabeth O’Donnell(Harvard University), Arnob Banerjee(Johnson & Johnson (United States)), Andrzej Jakubowiak(University of Chicago Medical Center), Farah Hossain, Frank Fan, Jordan M. Schecter(Centro de Investigación del Cáncer), William Deraedt(Janssen (Belgium)), Muhammad Akram(Unknown), Yi Lin, Xiaoling Wu(South China University of Technology), Tzu‐Min Yeh(Centro de Investigación del Cáncer), Indrajeet Singh(Janssen (United States)), Jeffrey R. Infante(Cancer Research Center), A. Keith Stewart(The University of Texas MD Anderson Cancer Center), Sen Hong Zhuang(Janssen (United States)), Marlene J. Carrasco, Alicia J. Allred(Queen's University Belfast), Dong Geng, Carolyn C. Jackson(Centro de Investigación del Cáncer)

Blood

November 4, 2020

Cited by 94

Related Papers

|Nature|2013|10.1k

|New England Journal of Medicine|2013|6.6k

|New England Journal of Medicine|2013|4.2k

|Nature Medicine|2020|2.7k

|New England Journal of Medicine|2012|2.1k